A University of Chicago spinout has raised $4 million in seed funding to develop a unique, saliva-based test for oral cancers ...

A large international trial is underway to determine whether CBD can help improve behavioral symptoms in people with tuberous sclerosis complex (TSC), a condition that affects about 90% of patients ...

Cadrenal Therapeutics highlights new research on the economic and medical burden associated with oral anticoagulation for LVAD patients.

Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer ...

PUNE, India, June 11, 2025 /PRNewswire/ — According to the latest report published by Credence Research, Inc., the global ...

TAMPA, FL / ACCESS Newswire / June 10, 2025 / Full Alliance Group, Inc. (OTC PINK:FAGI) today announced major strides in the commercial development of its recently formed subsidiary, Aquaox Pure Solut ...

Probiotic Ingredients Market The probiotic ingredients market is witnessing steady growth, driven by rising consumer demand for gut health ...

More migraine treatments than ever have become available in recent years, with more on the way. Discover the many options available in this comprehensive guide.

Roche’s Evrysdi (risdiplam) tablets have been approved by the European Commission (EC) to treat spinal muscular atrophy (SMA) ...

Basel: Roche has announced that the European Commission (EC) has approved a label extension for Evrysdi (risdiplam) to ...

European Commission approves Roche’s Evrysdi tablet to treat spinal muscular atrophy: Basel Thursday, June 5, 2025, 09:00 Hrs [IST] Roche announced that the European Commission ...